Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A computational algorithm for personalized medicine in schizophrenia.

Schizophrenia research - 1 Feb 2018

Lee Beom S, McIntyre Roger S, Gentle James E, Park Nan Sook, Chiriboga David A, Lee Yena, Singh Sabrina, McPherson Marie A

Abstract excerpt

Despite advances in sequencing candidate genes and whole genomes, no method has accurately predicted who will or will not benefit from a specific antipsychotic medication among patients with schizophrenia. We propose a computational algorithm that utilizes a person-centered approach that directly identifies individual patients who will respond to a specific antipsychotic medication. The algorithm was applied to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Associations and Epidemiology

Share to Pharmacogenomic Variants

Share to Polymorphism, Single Nucleotide

Share to Precision Medicine

Share to Schizophrenia

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 28495491
DOI: 10.1016/j.schres.2017.05.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A computational algorithm for personalized medicine in schizophrenia.PMID 28495491Read ↗

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.Semantic proximity Read ↗

Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.Semantic proximity Read ↗

Pharmacogenomics can improve antipsychotic treatment in schizophreniaSemantic proximity Read ↗

Pharmacogenetic intervention improves treatment outcomes in Chinese adult men with schizophreniaSemantic proximity Read ↗

Prediction of antipsychotics efficacy based on a polygenic risk score: a real-world cohort studySemantic proximity Read ↗

Pharmacogenomic scores in psychiatry: Systematic review of existing evidenceSemantic proximity Read ↗

Incremental predictive value of genetic risk and functional brain connectivity in determining antipsychotic response in schizophrenia.Semantic proximity Read ↗

Identifying a predictive model for response to atypical antipsychotic monotherapy treatment in south Indian schizophrenia patients.Semantic proximity Read ↗

Toward understanding genetic risk for differential antipsychotic response in individuals with schizophreniaSemantic proximity Read ↗

An Effective Method to Facilitate Personalized and Precise Medicine for Schizophrenia Treatment Based on PharmacogenomicsSemantic proximity Read ↗

Explainable AI enables clinical trial patient selection to retrospectively improve treatment effects in schizophreniaSemantic proximity Read ↗

Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.